4 results match your criteria: "Medical School of Bahcesehir University[Affiliation]"
Investigation of effective factors on traumatic amputations due to road traffic accidents.
Injury
March 2022
Biostatistics Department, Medical School of Van Yuzuncu Yil University, Van, Turkey.
Article Synopsis
- The study analyzed data from court files to identify factors related to traumatic limb amputations from road traffic accidents over a 10-year span.
- 63% of the cases involved males, with an average age of 29; most amputations occurred in lower limbs, primarily on the right side.
- The research highlights the need for larger studies to confirm findings and guide technology development aimed at preventing serious injuries that result in amputations.
Value of procalcitonin levels as a predictive biomarker for sepsis in pediatric patients with burn injuries.
Niger J Clin Pract
July 2019
Department of General Surgery, Medical School of Bahcesehir University, Istanbul, Turkey.
Aim: The aim of the present study was to investigate the value of serum procalcitonin (PCT) measurements for the prediction of sepsis in pediatric patients with burn injuries.
Method: All pediatric patients with burn aged between 1 and 15 years who were treated at Burn Centre of Kartal Training and Research Hospital, Istanbul, Turkey between January 2014 and January 2015 were included in this study. The patients were classified into three groups according to levels of serum PCT.
Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma.
Asian Pac J Cancer Prev
December 2013
Oncology of Department of Goztepe Medical Park Hospital, Medical School of Bahcesehir University, Istanbul, Turkey.
Background: Phase II and III trials of docetaxel, cisplatin and fluorouracil (DCF) have shown superior efficacy versus cisplatin and fluorouracil alone but with high rates of hematologic toxicity in metastatic gastric cancer cases. To reduce toxicity while maintaining the efficacy of DCF, we investigated low dose docetaxel (D), cispatin (C) - leucovorin and fluorouracil (De Gramont regimen).
Patient And Methods: Chemotherapy-naive patients with metastatic gastric cancer (MGC) received D 60 mg/m2 on day 1 and cisplatin 30 mg/m2 on day 1-2 and the De Gramont regimen (Folinic acid 400 mg/m2 on day 1 and 5-FU 2400 mg/m2/46 h continuous infusion) every 3 weeks.